Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer vaccine

Showing 7 posts of 7 posts found.

Pfizer sign

Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows

May 14, 2021
Medical Communications COVID-19, COVID-19 vaccine, Pfizer vaccine, pfizer-biontech vaccine, pharma, pharma news

The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed 12 weeks apart, a Birmingham …

News
Pfizer sign

Pfizer commences process for full FDA approval of COVID-19 vaccine

May 10, 2021
Sales and Marketing BioNTech, COVID-19 vaccine, FDA, Pfizer, Pfizer vaccine, pharma, pharma news

Pfizer and BioNTech have begun a Biologics Licence Application (BLA) with the FDA for full approval of their mRNA COVID-19 …

News
Pfizer's Lipitor tablet

Pfizer vaccine 91.3% effective after six months, Phase III study shows

April 6, 2021
Manufacturing and Production BioNTech, COVID-19, COVID-19 vaccine, Pfizer, Pfizer vaccine, pfizer-biontech vaccine

Pfizer and BioNTech’s follow-up study of their COVID-19 vaccine has confirmed the jab’s high efficacy after up to six months, …

News

North Korea accused of attempted Pfizer hack to steal COVID-19 vaccine data

February 16, 2021
Manufacturing and Production COVID, COVID Vaccine, COVID-19, North Korea, Pfizer, Pfizer vaccine, Vaccine

North Korea has tried to hack into Pfizer’s servers in order to ascertain its COVID-19 vaccine technology, according to a …

News

Pfizer COVID-19 vaccine proven 94% effective in biggest study yet

February 15, 2021
Sales and Marketing COVID-19, Pfizer, Pfizer vaccine, Vaccine, coronavirus

The Pfizer-BioNTech COVID-19 vaccine has been proven to be 94% effective, according to the first major study to evaluate the …

News
800px-pfizer_finland_hq_february_13_2009

Pfizer’s coronavirus vaccine shows moderate side-effects in clinical study

September 16, 2020
Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine

Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …

News
800px-pfizer_finland_hq_february_13_2009

Pfizer CEO says company’s COVID-19 vaccine will be available this year if FDA approves the candidate by October

September 14, 2020
Sales and Marketing Pfizer, Pfizer vaccine, Vaccine

Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general …

News

Latest content

EC approves Pfizer’s Emblaveo for multidrug-resistant infection treatment

April 22, 2024

Neurolentech and Kaerus Bioscience enter partnership for research on neurodevelopmental disorder

April 22, 2024

Ardena announces €20m expansion following first GMP approval

April 19, 2024

Roche’s Alecensa approved by FDA as lung cancer treatment

April 19, 2024

GSK shares results from phase 3 trial for gonorrhoea treatment

April 18, 2024